Literature DB >> 2295814

Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.

P Scott1, P Caspar, A Sher.   

Abstract

We have shown previously that BALB/c mice can be protected against a fatal infection with Leishmania major by adoptive transfer of a T cell line recognizing a protective soluble fraction (fraction 9) of promastigotes. We now describe the isolation and characterization of a T cell clone (9.1-2) that also transfers protective immunity against Leishmania. After Ag or mitogen stimulation, this clone secrets IL-2 and IFN-gamma, but not IL-4 or IL-5. The clone preferentially recognizes L. major fraction 9, and in addition, soluble Ag from Leishmania donovani, Leishmania amazonensis, and Leishmania braziliensis, but not from the related flagellates, Trypanosoma cruzi or Crithidia fasciculata. Besides being contained in fraction 9, the stimulatory Ag is also released from the parasite, because concentrated promastigote culture supernatants induced IFN-gamma production by 9.1-2. By means of T cell immunoblotting, we determined that 9.1-2 recognized a protein with a relative m.w. between 8,000 and 12,000, and within this region is a predominant protein contained in fraction 9 of approximately 10,000 m.w. These data identify a new candidate Ag for immunization against protozoa belonging to the genus Leishmania.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295814

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.

Authors:  P C Melby; J Yang; W Zhao; L E Perez; J Cheng
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response.

Authors:  C Kébaïer; H Louzir; M Chenik; A Ben Salah; K Dellagi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Induction of proliferative responses of T cells from Babesia bovis-immune cattle with a recombinant 77-kilodalton merozoite protein (Bb-1).

Authors:  C L Tetzlaff; A C Rice-Ficht; V M Woods; W C Brown
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

4.  Adaptive immune responses during Shigella dysenteriae type 1 infection: an in vitro stimulation with 57 kDa major antigenic OMP in the presence of anti-CD3 antibody.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Joydeep Mukherjee
Journal:  Mol Cell Biochem       Date:  2009-11-14       Impact factor: 3.396

5.  In vitro characterization of T cells from Mycobacterium w-vaccinated mice.

Authors:  I G Singh; R Mukherjee; G P Talwar; S H Kaufmann
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

6.  Cell-mediated immune responses to Babesia bovis merozoite antigens in cattle following infection with tick-derived or cultured parasites.

Authors:  W C Brown; K S Logan; G G Wagner; C L Tetzlaff
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

7.  In vivo imaging of transgenic Leishmania parasites in a live host.

Authors:  Colin J Thalhofer; Joel W Graff; Laurie Love-Homan; Suzanne M Hickerson; Noah Craft; Stephen M Beverley; Mary E Wilson
Journal:  J Vis Exp       Date:  2010-07-27       Impact factor: 1.355

8.  CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells.

Authors:  W H Alwan; F M Record; P J Openshaw
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

9.  Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. major.

Authors:  Cynthia M Theodos; Robin V Morris; Jeanette V Bishop; Jeremy D Jones; W Robert McMaster; Richard G Titus
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.

Authors:  F P Heinzel; M D Sadick; S S Mutha; R M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.